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The sequential  interactions between T  lymphocyte subsets have been well charac- 
terized in several systems of antigen-specific immune suppression  (1-2). The immune 
response to the hapten  4-hydroxy-3-nitrophenyl acetyl (NP) a has become one of the 
most  extensively  characterized  of these  model  systems  (3-6).  Previous studies  from 
our laboratory  have revealed  that  in  this  suppressor  network  system,  at  least  three 
distinct  sets of T  cells are required  for suppression.  The first set of suppressor T  cells, 
termed TSl, are induced by antigen, bear an idiotypic receptor, and function early in 
the immune response. These TSl induce a second set of suppressor T  cells, termed Ts2 
(3,  7). The Ts2 bear anti-idiotypic receptors and function late in the immune response 
(3-5).  Furthermore,  the  Ts2 population  or a  soluble  factor derived  from these  cells 
activates an antigen-primed Ts3 population that is thought to mediate the additional 
suppressor signals  (4).  Most studies,  including these in the NP system, appear to be 
fragmentary in that the entire sequence of cell interactions has not been fully defined. 
A  serious  limitation  of these  studies  has  been  the  lack of suppressor  cell  clones  or 
hybridomas to further characterize the different suppressor cell populations and the 
molecules responsible for the communication between these cells. 
For a better understanding of the precise nature and function of each participating 
suppressor  T  cell  subset,  we  have  recently  prepared  a  series  of monoclonal  T  cell 
hybridomas that  are specific for NP  (7-8).  We previously (7,  8)  characterized  these 
hybrids  and  demonstrated  that  they  correspond  to  the  Tsl  population.  We  now 
characterize another group of T  cell hybrids that corresponds to the Tsg population. 
Furthermore, we characterize the biologically active suppressor factor (TsF2) produced 
by these cells and compare it with the TsF1 factor obtained from the Tsl hybrids. 
Materials  and Methods 
Mice.  All mice were either purchased from The Jackson Laboratory, Bar Harbor, Maine or 
were bred in the animal facilities  at Harvard Medical School, Boston, Mass.  Mice were used at 
* Supported by grant AI 14732 from the National Institutes of Health, grant PCM 80-04573 from the 
National Science Foundation, and a grant from the Cancer Research Institute. 
1  Abbreviations used in this paper:  C, complement; CS, cutaneous sensitivity; DMSO, dimethyl sulfoxide; 
DNFB, 2,4-dinitro-l-fluorobenzene; HBSS, Hanks' balanced salt solution; NP, 4-hydroxy-3-nitrophenyl 
acetyl hapten;  NP-O-Su, NP-O-succinimide ester; RAMG, rabbit anti-mouse immunoglobulin; Ts~, Ts2, 
Tss, first, second, or third order suppressor T cells, respectively; TsF1, TsF2, suppressor factor derived from 
Tsl or Ts2 cells, respectively. 
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3-12 mo of age and were maintained on laboratory chow and acidified, chlorinated water ad 
lib. 
Antigens.  NP-O-Succinimide (NP-O-Su) was  purchased  from Biosearch Co.,  San Rafael, 
Calif. Dimethylsulfoxide (DMSO)  was purchased from Fisher Scientific Co., Pittsburgh, Pa. 
2,4-dinitro-l-fluorobenzene (DNFB)  was obtained from the Sigma Chemical Co.,  St.  Louis, 
Mo. 
NP-specific T Cell Hybridoma and TsF.  The methods for preparation of T cell hybridomas by 
polyethylene glycol-mediated fusion with the BW5147 tumor line were described previously 
(8). Our previous results (8) indicated that the CKB-Tsl-17 (Igh  b, H-2  k) and B6-Tsl-29 (Igh  b, 
H-2~  hybridoma lines, which  are  also  used  in this  report,  possess IoJ  and  NP  b idiotypic 
determinants. 
In addition to these Tsx lines, some Ts~ hybrids were also produced from the above fusions 
(7). This was not surprising because the Tsl and Ts2 populations were shown to coexist in the 
spleen at the time these cells were hybridized (3, 4, 9). The Ts2 lines isolated in this fashion 
include CKB-Ts2-59,  CKB-Tse-225, and  B6-Ts2-28.  The  other Ts2  lines were  obtained by 
hybridization of BW5147 cells with Ts2-containing  spleen cells. The enrichment of NP-specific 
Ts2 was described previously (3). Briefly, NP-primed C57BL/6 spleen cells were first fractionated 
on rabbit anti-mouse immunoglobulin  (RAMG)-coated polystyrene petri plates for 1 h at room 
temperature. The unbounded cells were then incubated on another set  of polystyrene petri 
plates  coated  with  purified  C57BL/6  anti-NP  antibodies  for  1  h  at  room  temperature. 
Nonadherent cells were removed, and adherent cells were incubated on ice for 30 min. The 
adherent cells were resuspended by vigorous pipetting. These enriched Ts2 populations were 
fused by polyethylene glycol with the BW5147 tumor cell line, as described in detail elsewhere 
(8). 
The  hybridized Ts2 candidates were  screened  using a  cytotoxicity test  (8)  with  anti-I-J 
alloantisera. All the Ts2 hybrids (CKB-Ts2-59, CKB-Ts~-217, CKB-Ts2-225, B6-Ts2-28, and B6- 
Ts~-14)  were  periodically passed  over  C57BL/6  anti-NP  antibody-coated plates,  and  the 
idiotype-adherent cells were used to maintain the cell lines. The CKB-Ts~-59  and B6-Ts2-28 
hybridoma lines were cloned by limiting dilution, and each of the five clones tested had the 
same phenotype and suppressive activity as the parental line. 
All of the hybridomas were cultured in RPMI 1640 containing 8% fetal calf serum and 0.01 
M Hepes buffer. The suppressor factors used in the ~resent experiment were collected from the 
cultured supernates of cells at a density of ~7 ×  10  cells/ml in the above medium. 
Adsorption and Elution of TsF.  The methods of adsorption and elution of TsF using protein- 
conjugated Sepharose 4B columns were described in detail previously (8). 
Absorption of TsF with T Cells.  T  cells were enriched from immune lymph node cells using 
RAMG-coated plastic petri dishes as described above. 1 ml of Ts2 factor was incubated with 4 
×  107 immune lymph node T cells or 2 ×  106 hybridoma T cells for 1 h on ice with intermittent 
mixing. Then the  supernates were  centrifuged and  tested  for  suppressor activity at  a  1:5 
dilution. 
Assay for the Ability  of TsF to Induce Suppressor Cells. To make Ts2 cells  for  in vivo studies, 
hybridoma TsF1  (0.3 ml) was  injected i.v.  into naive mice for  4 successive  days. On day 6, 
spleens from these mice were removed, and a single cell suspension was prepared in Hanks' 
balanced salt solution (HBSS).  4 ×  107 spleen cells were washed three times with HBSS and 
injected into NP-primed mice (7). The recipient mice were then challenged with NP, and the 
swelling responses  were measured 24 h later, as described elsewhere  (4). 
Assay for Suppressive Activity of TsF on NP-mediated Cutaneous Sensitivity (CS)  Responses.  The 
assay for NP-specifie CS responses was described elsewhere  (4). Briefly, each animal was primed 
subcutaneously with 7 mg of NP-O-Su in DMSO. Unless indicated otherwise, the hybridoma 
factors were tested in the effector  phase, 5 or 6 d  after priming. 0.4  ml of each hybridoma 
supernate or BW5147 control supernate was injected intravenously on the day before and the 
day of antigen challenge. 6 d after immunization, 25 #g of NP-O-Su in 0.025 ml of phosphate- 
buffered saline, pH 7.2, was injected into the left footpad. Footpad swelling was measured 24 
h  after challenge. Swelling was determined as the difference, measured in units of 10  -3 cm, 
between the left and right footpad thickness. 
DNFB Responses.  Contact sensitivity was induced by painting the shaved abdomen twice 1392  CHARACTERIZATION OF TsF2 SUPPRESSOR FACTOR 
daily with 25/~1 of 0.5% DNFB solution  (Sigma Chemical Co.) in acetone:olive oil (4:1) (7). 6 
d after the last painting, 20/~1 of 0.2% DNFB in the same vehicle was applied to the left ear, 
and the ear swelling was measured as the difference between the left and right ear thicknesses. 
Percent Suppression.  The  percent  suppression  in  the  present  study was  calculated  by the 
following formula: 
percent suppression  =  100 ×  [(swelling of BW5147 tumor supernate-injected group -  swelling 
of TsF-injected group) /  (swelling of BW5147  tumor supernate-injected group -  swelling of 
unprimed group)]. 
Data Analysis.  Statistical  analysis  of the experimental data with  respect  to controls  was 
calculated using the two-tailed Student's t-test. 
Results 
Screening of Hybridoma Suppressor Cells.  Suppressor cells were initially  induced  by 
the intravenous injection of 4 ×  107 NP-coupled syngeneic spleen cells. The suppressor 
T  cells  were  purified  by successive passage over RAMG  and  NP  b idiotype-coated 
plates.  The idiotype-adherent T  cells were fused with the AKR BW1547  thymoma 
tumor line with polyethylene glycol; selection of hybrids seeded at a concentration of 
103 spleen cells per well was carried out with hypoxanthine-aminopterin-thymidine 
selective media. Hybridoma colonies were noted in ~25% of the wells seeded. When 
the  colonies  were  large  enough  for passage,  an  aliquot  of cells  was  tested  for the 
presence  of I-J  alloantigenic  determinants  by  microcytoxicity testing.  23%  of the 
colonies  tested  could  be  specifically  lysed  with  allele-specific  anti-I-J  alloantisera. 
Supernates from the I-J-positive colonies were then screened for in vivo suppression 
of NP-specific CS  responses.  0.4  ml of supernatant  fluid was administered  intrave- 
nously on the day before and the day of antigen challenge. In addition to the above 
supernates, several other I-J-positive cell lines from previous fusions were also screened 
in this assay system. Five of the cell lines that manifested at least 50% suppression of 
the CS immune response were saved for further analysis. 
The hybrid cell lines that produced suppressor factors were also screened for other 
cell surface markers by microcytotoxicity testing. All hybridoma cell lines were lysed 
with anti-Thy- 1.1 antisera and with one exception (CKB-Ts2-59) were also lysed with 
anti-Thy-l.2 antisera, which  detected the Thy-l.2 gene products introduced  by the 
parental suppressor cell donors.  Preliminary analysis with the anti-Lyt-2 monoclonal 
antibody  suggests  that  several  of the  Ts2  hybrids  may also  carry  this  cell  surface 
marker (data not shown).  However, none of the cell lines could by lysed with anti- 
NP  b idiotype antiserum plus complement (C) (data not shown), which contrasts with 
the results noted with a previous series of Ysa hybrids that could by lysed by the latter 
reagent (8). 
Finally, it should be noted that the ability to lyse these cell hybrids with anti-I-J 
alloantibody plus C  has proven to be a variable feature of these cell lines. With time, 
there  appeared to be a  continual  decrease  in  the  level of surface  I-J determinants 
expressed on these cells. We have recently noted similar decreases in the level of I-J 
determinants expressed on the surfaces of Tsl hybridoma cell lines. 
Specificity of Suppressor Factors.  To test the biological activity of these presumptive 
suppressor hybrids, we screened  for the ability of culture supernates obtained  from 
cells growing at a  density of ~7  ×  105 cells/ml to suppress in vivo CS responses. As 
shown  in Table I, intravenous  injection of 0.4  ml of supernate  from the B6-Ts2-28, MINAMI  ET  AL.  1393 
B6-Ts2-14,  and  CKB-Ts2-225  cell  lines specifically suppressed  NP-induced  CS  re- 
sponses. The supernates demonstrated maximum or plateau levels  of activity when 
given either undiluted or diluted 1:10. In these experiments the percent of suppression 
ranged from 50-75%. After further dilution, these materials no longer demonstrated 
suppressive activity. The failure of these factors to induce complete suppression of the 
CS response, coupled with the plateau level of suppression, suggested that they might 
be maximally effective if the different monoclonal factors derived from each strain 
were mixed. In three separate experiments, we observed that the percent of suppression 
was consistently greater when mice were given a  mixture of suppressor factors, but 
the differences were small and not statistically significant. 
The  antigen  specificity of these  suppressor  factors  was  demonstrated  by  their 
inability to suppress DNFB-induced contact sensitivity responses (Table I). The NP 
specificity of the  CKB-Tsz-59  and  CKB-Ts2-217  suppressor  factors  was  similarly 
established (data not shown). 
Comparison of Tsl  and  Ts2-derived Factors.  To  compare  this  series  of NP-specific 
suppressor factors with the previously characterized set of Tsl hybridoma factors, we 
determined  the  phase  of the  immune response  in  which  the  various  factors were 
active. 0.4 ml of factor was injected intravenously either on the day of and the day 
after antigen priming  (induction phase)  or the day before and the day of antigen 
challenge (effector phase). In confirmation of our previous data, the B6-Tsr29  and 
CKB-Tsr 17 factors only demonstrated suppressive activity when administered during 
the induction phase of the immune response  (Table II). In contrast, the B6-Ts2-28, 
B6-Ts2-14,  CKB-Ts2-59,  and  CKB-Ts2-225  factors  only suppress  the  NP  response 
when administered during the effector phase (Table II). 
We have previously demonstrated (7)  that Tsr and Tsx-derived factors induce a 
TABLE  I 
Specificity of Hybridoma Suppressor Factors* 
Source of  Strain tested  TsF dilution  TsF 
Swelling response 
(x  10  -s cm) ±  SE 
NP-O-Su  DNFB 
BW5147  C57BL/6  Undiluted  22.0 ±  3.4  12.6 ±  2.1 
B6-Ts2-28  C57BL/6  Undiluted  8.5 ±  1.5~:  19.3 ±  4.6 
1/10  a.0 ±  1.0~ 
1/100  18.2 :t= 2.4 
B6-Ts2-14  C57BL/6  Undiluted  11.2 ±  1.3~  19.6 ±  5.5 
1/10  12.0 ±  1.0:~ 
1/100  19.0 ±  2.2 
BW5147  B10.BR  Undiluted  23.5 ±  1.3  17.6 +  1.8 
CKB-Ts2-225  B10.BR  Undiluted  14.4 +  1.7:~  17.3 +  2.8 
1/10  14.8 +  1.4~ 
1/100  23.5 ±  1.8 
* Groups of four to five mice were immunized with either NP-O-Su or DNFB. On the 
day before and the day of antigen challenge, mice were given an injection of 0.4 ml 
i.v. of either control BW5147 or suppressor factors. The background responses of 
nonimmunized C57BL/6  mice were  3.5  +  0.9  and  0.5  ±  0.6  for  NP-O-Su  and 
DNFB, respectively. The background responses of B 10.BR mice were 6.4 +  1.1 and 
2.4 ±  0.9 for NP-O-Su and DNFB, respectively. 
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TABLE  II 
Suppression of the Induction vs. Effector Phase of the Immune Response* 
NP-O-  Source of  Strain tested  Su  TsF  priming 
Footpad swelling 
(× 10  -s cm) ±  SE 
Induction  Effector 
phase  phase 
None  C57BL/6  +  19.0 ±  0.9  19.0 ±  0.9 
B6-Tsl-29  C57BL/6  +  7.4 ±  0.7~  18.6 :t: 1.7 
B6-Ts2-28  C57BL/6  +  18.2 ±  1.3  12.2 ±  1.5~ 
B6-Ts2-14  C57BL/6  +  17.8 ±  1.1  12.2 ±  2.1:~ 
None  C57BL/6  -  5.4 ±  0.6  5.4 ±  0.6 
None  B10.A  +  25.0 ±  2.5  25.0 ±  2.5 
CKB-Tsl-17  B10.A  +  8.6 ±  2.8:~  31.0 ±  4.5 
CKB-Ts2-59  B10.A  +  26.8 ±  4.3  12.4 ±  2.4~: 
CKB-Ts2-225  B10.A  +  25.4 ±  4.5  11.4 ±  2.7:~ 
None  B10.A  -  9.6 ±  1.4  9.6 ±  1.4 
* Groups of four to five mice were immunized with NP-O-Su and were given 
TsF  either at  the  time of antigen  priming  (induction  phase)  or  antigen 
challenge (effector phase). 
Significant suppression, P <  0.01. 
TABLE  III 
Comparison of the Ability of TsFI and TsF2 to Generate Suppressor Cells* 
Strain for Ts  Source of TsF  generation 
Transfer recipients 
NP-O-Su  Footpad swelling 
priming  ±  SE 
BW5147  B10.BR  +  31.2 +  1.9 
CKB-Tsl-17  B10.BR  +  12.4 +  2.2:~ 
CKB-Ts2-59  B10.BR  +  33.8 +  1.9 
CKB-Ts2-225  B10.BR  +  33.8 ±  3.1 
None  None  -  8.2 ±  2.0 
* Groups of four to five NP-O-Su-primed B10.BR mice received 4 ×  10  7 spleen 
cells from donors that were treated with TsF. The mice were challenged 1- 
2 h. after cell transfer. Footpad swelling was measured 24 h after challenge 
in units of 10  -s cm. 
:~ Significant suppression, P <  0.01. 
second  population  of suppressor  T  cells.  To  determine  whether  this  new  series  of 
factors could also induce suppressor cells, B 10.BR mice were given four (day 0 through 
day 3)  intravenous  injections of 0.4 ml of TsF.  6  d  later the animals were killed,  and 
4  ×  107  splenocytes  were  adoptively  transferred  into  NP-O-Su-primed  syngeneic 
recipients that were challenged  1-2 h  after the cell transfers. The data shown in Table 
III  confirm  that  hybridoma  CKB-Tsa-17-derived  factor  can  induce  second-order 
suppressor cells. In contrast, the CKB-Ts2-59 and CKB-Ts2-225 factors fail to generate 
another  population  of  suppressor  cells.  Thus,  we  can  conclude  that  the  factors 
characterized in the present report are different from the Tsl-derived factors previously 
characterized,  and  this  new  group  of hybridoma  cell  lines  represents  Ts2  cells  that 
produce  a  biologically active suppressor factor termed  TsF2. 
Immunochemical  Characterization  of TsF2.  To  further  distinguish  the  CKB-Ts~-225, MINAMI ET  AL.  1395 
CKB-Ts2-59,  and  B6-Ts2-28  factors from  the previously described Tsa factors, these 
materials were  passed over a  series of immunoadsorbent  columns.  The  suppressive 
activity of the CKB (H-2k)-derived factors could be depleted by passage over anti-I-J  k 
columns but  not  anti-I-J  b columns.  In contrast,  the C57BL/6  (H-2b)-derived factor 
was  specifically adsorbed  by  anti-I-J  b  columns.  The  suppressive  activity could  be 
recovered by acid elution (Table IV). The suppressive activity of the B6-Ts2-28, CKB- 
Tsz-59 and CKB-Ts2-225-derived suppressor factors were not adsorbed by polyvalent 
guinea pig anti-immunoglobulin columns, guinea pig anti-idiotype columns, or NP- 
KLH columns. This contrasts with the results obtained with B6-Tsx-29-derived factor 
that  could be specifically adsorbed by either anti-idiotype or NP-KLH  immunoad- 
sorbent  columns  (Table IV).  However,  the Ts2  derived but  not  Tsx-derived factors 
could  be  depleted  on  NP  b  idiotype  columns.  Furthermore,  the  TsF2  suppressive 
activity was recovered by acid elution from the NP  b idiotype columns. The specificity 
of the adsorption was controlled by the demonstration that the factors could not be 
adsorbed  on  columns  containing  nonimmune  mouse  immunoglobulin  (Table  IV). 
Thus, we conclude that these TsF2 bear I-J determinants and have a specific receptor 
for NP  b idiotype. 
Cellular  Absorption  of  TsF2.  The  binding  of  TsF2  suppressive  activity  to  NP  b 
idiotype-bearing immunoadsorbent  columns indicated that  these hybridoma factors 
bound to B  cell-derived immunoglobulin products. In the next series of experiments, 
the ability of TsF2 to bind to T  cells was established.  1.0 ml of CKB-Ts2-59-derived 
factor was absorbed with 4  ×  107 B10.BR  RAMG-purified lymph node T  cells from 
mice that were primed 1 wk previously with either NP-O-Su or DNFB. Only the NP- 
O-Su-primed cells could absorb the TsF2 suppressive activity (Table V). In addition, 
B6-Ts2-14-derived  factor  was  also  specifically  absorbed  with  NP-O-Su  immune 
C57BL/6 T  cells (Table V). To assess the influence of H-2 genotype on the ability of 
NP-O-Su  immune  T  cells  to  absorb  TsF2  activity,  CKB-Ts2-59  factor  (I-J  k)  was 
absorbed  with  C57BL/6  (H-2  b)  NP-O-Su-primed  T  cells.  The  data  in  Table  V 
demonstrate that C57BL/6 T  cells can absorb CKB-derived TsF2, indicating that H- 
2  homology is not  required between  the strain  producing the TsF2 and  the T  cells 
TAnLE  IV 
Immunochemical Characterization of Hybridoma Suppressor Factors* 
Immunoad-  B6-Tsl-29  B6-Ts2-28  CKB-Ts2-59  CKB-Ts:,-225 
sorbent col- 
umns  Unbound  Eluate  Unbound  Eluate  Unbound  Eluate  Unbound  Eluate 
None  83  75  65  68 
Anti-IJ  k  89  -  17  63  19  5  75  23 
Anti-IJ  b  0  72  10  77  72  0  76 
Anti-Ig  89  11  75  17  77  -  1  50 
Anti-NP  b  22  83  67  12  70  28  37 
NP  b  71  -  1  9  86  4  68  0 
Ig  69  5  48  -6 
NP-KLH  17  69  61  10  92  -  1  l 
77 
5 
1 
--1 
104 
*  Hybridoma-derived TsF containing supernatant fluids were adsorbed  onto various columns and the 
unbound and acid-eluted fractions were tested for suppressive activity in either C57BL/6  or BI0.BR 
recipients. Some of the results using the control B6-Ts~-29-derived  TsF were previously published  (7, 8). 
The data are expressed as the percent suppression of the NP-O-Su CS response compared with BW5147 
supernate controls. Less than 30% suppression is not considered significant. 1396  CHARACTERIZATION OF  TsF2  SUPPRESSOR  FACTOR 
TABLE V 
Absorption of TsF2 Factors with  T Cells* 
T  cells used for absorption 
Source of TsF  Percent sup- 
Strain or hybridoma  Priming  pression ±  SE 
antigen 
BW5147 
CKB-Ts2-59 
None  None  0 ±  8 
None  None  7t ±  5~: 
BI0.BR  NP-O-Su  -2 ±  9 
B10.BR  DNFB  61  ±  10:~ 
C57BL/6  NP-O-Su  16 ±  5 
CKB  NP-O-Su  4 ±  8 
C3H  NP-O-Su  53 
B6-Tsl-3  -9 
±  8~: 
±  12 
B6-Tsl-29  1 +  17 
CKB-Tsl-17  14 +  20 
CKB-Tsl-19  14 ±  24 
CKB-Tsl-39  8 +  19 
AKR (BW5147  tumor)  76 +  13:~ 
B6-Ts~- 14  None  None  76 +  7:1: 
C57BL/6  NP-O-Su  15 ±  12 
C57BL/6  DNFB  71 ±  13:~ 
* 1 ml of hybridoma-derived TsF2 was absorbed with either 4 X  10  7 NP-O-Su- 
or DNFB-primed lymph node T  cells from mice of the strains listed or with 
5 ×  l0  s Tsx hybridoma T  cells. The factor was then diluted  1:5 and 0.4  ml 
was injected  i.v.  on the day before and the day of antigen challenge.  The 
data  represent the pooled results from three separate experiments (not all 
groups were included  in each experiment). The data were normalized and 
the percent suppression ±  SE was calculated. 
Significant suppression, P <  0.01. 
used for absorption.  To determine whether a  requirement for Igh homology exists, 
CKB-Ts2-59 factor was absorbed with CKB  (Igh  b) or C3H  (Igh  j) NP-primed lymph 
node T  cells. The C3H  cells  failed to absorb  significant  levels of TsF2 suppressive 
activity,  whereas  T  cells  from  the  Igh  congenic CKB  strain  depleted  suppressive 
activity (Table V). Finally, we attempted to absorb TsFz activity with 5 X  l0  s NP  b 
idiotype-bearing Tsl  hybridoma cell lines  derived  from either C57BL/6  (H-2  b)  or 
CKB  (H-2  k)  donors. As also shown in Table V, each of these Tsl hybrids absorbed 
TsF2 activity, whereas two nonfunctional B6 T  cell hybridoma lines (data not shown) 
and the BW5147 tumor line that was used to prepare the hybrids failed to absorb the 
suppressive activity. Thus, Ts2-derived suppressor factor can specifically bind antigen- 
primed T  cells or hybridoma cells that bear idiotypic determinants. Furthermore, the 
binding of TsF2 to idiotypic T  cells does not require H-2 homology. 
Genetic Restriction of TsF2.  We have previously characterized (4,  7, 9)  the genetic 
restrictions of the splenic Ts2 cell population.  The results of these past experiments 
indicated that this population had a dual restriction for both H-2 and Igh-V complex 
genes. Because these experiments always used a  heterogeneous population of cells, it 
was never clear whether one group of Ts2 cells was Igh restricted and another subset 
was H-2 restricted. The production of monoclonal Ts2 hybridoma lines now permits 
definitive analysis of this issue.  The data in Table VI demonstrate that monoclonal 
TsF2 factors are restricted by both H-2 and Igh genes. Thus, CKB-Ts2-59, CKB-Ts2- 
225,  and  CKB-Ts2-217 factors that  are derived from cells that  carry the  H-2  k and MINAMI ET AL. 
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Genetic Restriction of TsF2  * 
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Source of TsF 
NP-O-Su 
priming 
Recipient strains 
Bf.lgh"  C57BL/6  B 10.BR  C3H  CKB  CWB 
(H-2  h  , Igh  ~)  (H-2", lgh  b)  (H-2  a  , Igh~  (H-2  k  , lgh  ~)  (H-2  a  , Igh  ~)  (H-2  b  , Igh  t') 
BW5147  +  18.1 ±  2.5  20.5 ±  1.1  17.3 ±  1.7 
CKB-Ts2-59  +  19.3 ±  1.7  12.2 ±  1.8:~  17.5 ±  1.3 
CKB-Ts2-225  +  19.8 ±  1.6  13.2 ±  1.2,  17.0 ±  2.0 
CKB-Ts2-217  +  20.2 ±  0.9  11.4 :t: 1.6~  16.8 ±  2.3 
BW5147  5.9 :l: 0.5  7.9 ±  1.2  2.2 ±  0.5 
BW5147  +  18.4 ±  1.1  19.6 ::t: 2.9  19.6 ±  1.7 
B6-Tsz-28  +  17.3 ±  2.2  7.6 ±  1.2~:  18.4 ±  1.0 
B6-Ts2-14  +  20.0 ±  0.9  7.2 ±  1.2,  22.6 ±  0.8 
BW5147  2.0 ±  0.9  3.6 ±  1.0  9.0 +  2.1 
BW5147  +  25.2 +  2.8  22.0 ±  1.3  20.4 :t: 2.6 
CKB-Ts2-225  +  27.2 ±  1.4  9.5 ±  3.5:~  18.4 ±  1.7 
CKB-Ts2-59  +  21.6 ±  2.1  8.6 ±  3.1~  20.5 ±  4.5 
BW5147  -  2.0 ±  1.7  4.3 ±  2.7  4.8 ±  1.8 
* Groups of four to five mice were immunized with NP-O-Su and were given TsF during the effector phase of the immune response.  The data 
are expressed  as the increment of footpad swelling +  SE in units of 10  -a cm. 
:~ Significant suppression,  P <  0.01. 
Igh  b haplotypes only supress NP-induced CS responses of CKB (H-2 k, Igh  b) or B 10.BR 
(H-2  k,  Igh  b)  mice. These factors fail  to  suppress  NP-induced CS  responses  in  Igh 
congenic C3H  (H-2 k, Igh  j) mice or H-2 eongenic CWB (H-2 b, Igh  b) mice. Similarly, 
the C57BL/6 (H-2 b, Igh~-derived factors suppress the CS responses of C57BL/6 mice 
but  fail  to suppress  NP-specific responses  induced in Igh congenic B6.Igh  e or H-2 
congenic  B10.BR  recipients  (Table  VI).  These  experiments were  repeated  using 
monoclonal TsF2  derived  from  the  cloned  B6-Ts2-28  and  CKB-Ts2-59  cell  lines; 
comparable data were obtained (data not shown). 
Intra-H-2 Mapping of TsF2 Restrictions.  To determine which subregions of the H-2 
complex restricted TsF2 activity, the B6-Ts2-28, CKB-Tsz-59, and CKB-Ts2-225 factors 
were tested in B10.MBR  (K  b, I k, S  k, Dq), B 10.A(3R)  (K  b, IA  b, IB b, IJ  b, IE  k, IC  d, S  d, 
Dd), B 10.A(4R)  (K  k, IA  k, IB  b, IJ  b, IE  b, IC  b, S  b, Db), and B 10.A(5R) (K  b, IA  b, IB  b, IJ  k, 
IE  k,  IC  d,  S  d,  D d)  NP-O-Su-primed  recipients.  The  results  of  three  independent 
experiments were pooled (Table VII). The C57BL  (H-2b)-derived  B6-Ts2-28 factor 
suppressed NP responses  in H-2K-, I-A-, I-B-, and I-J-compatibile B10.A(3R)  and I- 
B-, I-J-, I-E-,  I-C-,  S-, and H-2D-compatible B10.A(4R)  mice but failed to suppress 
H-2K-compatible B10.MBR or H-2K-, I-A-, and I-B-compatible B10.A(5R)  recipi- 
ents.  In  contrast,  the  CKB  (H-2k)-derived CKB-Ts2-59  and  CKB-Ts2-225  factors 
suppressed I-A-, I-B-, I-J-, I-E-,  I-C-, and S-compatible B10.MBR and I-J- and I-E- 
compatible B10.A(5R)  recipients but failed to suppress  I-E-compatible B 10.A(3R) or 
H-2K- and I-A-compatible B10.A(4R)  recipients. Thus, it appears that I-J homology 
is required between the TsF2 donor and recipient strains for factor activity. 
Discussion 
We characterize five T  cell  hybridomas that  correspond to  the Ts  e or Ts2 cells 
previously identified in the NP system. These hybrids differ from three other NP- 
specific suppressor T  cell hybridomas previously characterized that represented Tsx 
cells. The differences between the hybridoma Tsa and Ts2 surface phenotypes correlate 1398  CHARACTERIZATION OF TsF~ SUPPRESSOR  FACTOR 
TABLE VII 
Intra-H-2 Mapping of TsF2 Restriction  * 
Source of  NP-0-Su 
TsF2  priming 
Recipient strains 
B10.MBR  B10.A(3R)  B10.A(4R)  B10.A(SR) 
(bkkkkkkq)  (bbbbkddd)  (kkbbbbbb)  (bbbkkddd) 
BW5147  +  29.3 + 2.7  24.8 + 2.0  20.6 +  1.2  23.1 +  1.9 
B6-Ts2-28  +  31.6 ± 3.5  15.0 ±  1.65  11.1 ±  1.35  20.7 ±  1.4 
CKB-Ts2-59  +  16.3 +  1.65  23.5 + 2.0  19.6 + 2.8  16.4 +  1.65 
BW5147  -  10.6 ±  1.8  8.5 ::lz 1.1  6.6 ±  1.1  10.3 ± 0.9 
BW5147  +  29.8 + 2.8  25.2 + 2.2  20.8 ±  1.1  23.2 +  1.7 
CKB-Ts2-225  +  19.3 ± 2.55  23.6 ±  1.8  20.6 ± 2.9  14.8 ±  1.55 
BW5147  -  10.1 +  1.9  8.4 +  1.2  7.6 + 0.8  9.7 +  1.2 
* Groups of 12-15 mice were immunized  with  NP-O-Su and were given TsF during the 
effector phase of the CS response. The data are expressed as the increment  of footpad 
swelling + SE in unis of 10  -3 cm. The alleles at the H-2K, IA, IB, IJ, IE, IC, S, and H-2D 
regions of the recipient strains are indicated in parentheses. 
$ Significant suppression, P < 0.05. 
with those noted between the splenic Tsx and Ts2 populations in  the NP and other 
systems (1, 2, 4). Thus, Tsl cells bear I-J, Thy-1, and idiotypic determinants, whereas 
Ts2 cells bear the I-J and Thy-1  markers but  lack NP  b idiotypic determinants.  The 
Ts~  hybridoma cells generally display the same surface phenotype but  occasionally 
some hybrids lose the parental Thy-l.2 marker, e.g., CKB-Ts2-59, presumably due to 
loss of the parental chromosome coding for this marker (8). 
The  antigen-specific suppressor activity of the Tsz  hybridoma culture supernates 
also  has  several  features  that  distinguish  it  from  the  previously characterized  Tsr 
derived factors. First, TsF2 functions during the effector phase of the immune response, 
whereas TsF1 only induces suppression when given during the induction phase. These 
differences  in  the  kinetics  of TsF  activity reflect  differences  in  the  mechanism  by 
which  these factors function.  Thus,  TsF1 induces a  second population of suppressor 
cells  (Table  III  and  reference  8),  whereas  TsF2  presumably  activates  an  antigen- 
primed Tsa target population. Because TsF2 does not function when given during the 
induction phase of the immune response, we assume that this material, in the absence 
of the appropriate target cells, has a  very short biological half-life. 
The secOnd method used  to distinguish these two I-J-bearing factors is to charac- 
terize the binding properties of each  factor. As shown  in Table IV, TsFx bears NP b 
idiotypic determinants and binds to hapten-coupled immunoadsorbant  columns.  In 
contrast, TsF2 lacks NP  b idiotypic determinants and hapten-binding specificity, but 
can specifically bind to NP  b idiotype or to T  cells that  bear NP  b idiotypic determi- 
nants,  i.e.,  the  Ts2-derived  factor  is  anti-idiotypic. The  specificity of these  factors 
correlates with the specificity of the Tsl and Ts2 cell surface receptors. Thus, Tsl cells 
bear NP  b idiotypic determinants  and  can  bind hapten,  whereas  the Ts2 population 
bears anti-idiotypic receptors (3-5). These correlations between Ts and TsF specificity 
support the notion that TsF may represent a  solubilized membrane receptor. 
It is important to note the specificity of cellular absorption of TsF2 (Table V). Thus, 
TsF2 can  be absorbed by H-2-compatible or  H-2-incompatible NP  immune  T  cells 
but not by T  cells primed with another antigen. These findings contrast with those of MINAMI ET AL.  1399 
Taniguchi  et  al.  (10),  who  demonstrated  that  in  their  system,  suppressor-factor 
binding was H-2 restricted and their suppressor factor could be absorbed by normal 
T  cells.  These authors  postulated  (10)  that  TsF binding  was  controlled by an  I-J 
acceptor  site  on  a  subpopulation  of suppressor  T  cells.  Because  of these  major 
differences between the two systems studied, we conclude that the factors and cellular 
interactions described in  the  latter report may relate to other suppressor products 
(perhaps Ts~) rather than those described in this report. 
The third method for distinguishing between the TsF1 and TsF2 factors is by the 
genetic restrictions required for factor activity. Thus, TsF1 factor will suppress antigen- 
primed mice that are H-2 incompatible with the strain producing the factor (7).  In 
contrast, TsF2 can only suppress antigen-primed mice that share H-2 genes with the 
strain producing the TsF2 factor. The nature of the TsF2 H-2 restriction is not clear 
because NP  b idiotype columns that lack H-2 determinants and NP-immune T  cells 
from H-2 incompatible mice can absorb the factor (Tables IV and V). To account for 
these  paradoxical  observations  we  propose  the  following possibilities:  (a)  the  H-2 
restriction reflects a pseudogenetic restriction in which TsF2 activates an H-2-restricted 
Ts3 cell population.  Pseudogenetic restrictions involving Tsa cells and  factors have 
been well documented in the NP and other systems (7,  1 I, 12). Alternatively, (b) the 
Tsa cells (which are considered to represent the cellular targets of TsF2) might have a 
receptor that  recognizes H-2  determinants  on  TsF2.  Activation  of Tsa  cells  might 
therefore require the simultaneous stimulation of both idiotypic and H-2 receptors, 
resulting in an apparent dual genetic restriction. This could account for the ability of 
H-2-incompatible cells  to  absorb  the  H-2-restricted TsF2.  Further experiments are 
required to understand  the nature of the dual  H-2 and  Igh restriction of the TsF2 
factor.  However,  the  present  results  demonstrate  that  these  dual  restrictions  are 
properties of monoclonal factors from a series of hybridoma T  cell lines. 
The genetic restrictions of antigen- or TsFl-induced Ts2 cells have been previously 
characterized. We and others (3, 4, 6) have demonstrated that this cell population is 
both Igh and H-2I restricted. One series of experiments attempted to dissect the H-2 
restriction of Ts9 cells and demonstrated that genes in the I-A subregion control this 
restriction. However, those previous experiments (9) involved the in vivo transfer of 
immunocompetent splenic Ts2 cell populations into allogeneic recipients. We assumed 
that the potential allogeneic effects had no influence on suppressive activity. However, 
Bromberg et al.  (13)  recently demonstrated the activitation of T  suppressor cells by 
an  allogeneic effect. Thus,  the conclusions from our previous experiment  must  be 
reinterpreted  in  view of this complicating factor. In  the  present  experiment, three 
different monoclonal TsF2 factors were used to investigate genetic restrictions. Because 
soluble factors were used  in  the present  experiments instead  of immunocompetent 
cells, we believe that the potential complications introduced by allogeneic effects have 
been  eliminated.  Therefore, the  I-J  and  Igh  restrictions  observed  in  the  current 
experiments probably reflect the restrictions on the Ts2 cell population. Tada et al. 
(14)  had  previously demonstrated the involvement of I-J restrictions in  a  different 
suppressor  cell  system,  but  the  restictions  in  still  other  systems  have  mapped  to 
different regions of the H-2 complex (15-17). The reasons for these apparent discrep- 
ancies are not clear; they might reflect interactions between different suppressor cell 
subsets or alternative receptors on some Ts populations. 
The present results can be combined with previous data on the NP suppressor cell 1400  CHARACTERIZATION OF TsF2 SUPPRESSOR FACTOR 
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FIG.  1.  Immunoregulation of NP-induced immune responses. A  schematic representation of the 
cellular populations in the suppressor pathway. See text for details. 
system  to  describe  an  overall  suppressor  pathway.  A  similar  pathway  has  been 
proposed (1)  for suppression to a variety of other antigens. As summarized in Fig.  1, 
entry into the suppressor pathway can be obtained by the intravenous administration 
of antigen-modified syngeneic cells. In a  different suppressor cell system, Sherr et al. 
(18)  demonstrated that the antigen must be associated with Ia-positive adherent cells 
to induce immune suppression. The first cell observed in the suppressor pathway is a 
cyclophosphomide-sensitive,  I-J-bearing  Tsl  cell  that  binds  antigen.  The  antigen 
receptor on this cell was studied  using a  series of Tsl hybridoma cell lines, and the 
data indicated that both the I-J and idiotype determinants were functionally involved 
in the antigen receptors of Tsl cells (8). The culture supernates of the monoclonal Tsl 
hybrid lines contain a  biologically active suppressor factor termed TsFs. This factor 
bears I-J and idiotypic determinants. In the absence of antigen, TsF1 induces a second 
population of suppressor cells termed Ts2. The ability of Tsx and TsF1 to induce Ts2 
cells is not  restricted  by either H-2- or Igh-linked genes.  However, the Ts2 that  are 
generated  will  only function  in  strains  of mice bearing the  appropriate Igh alleles. 
This type of apparent Igh restriction was termed a pseudorestriction  (7). 
The Ts2 cell population bears Lyt-2 and I-J determinants and has an anti-idiotypic 
receptor (3, 4).  In contrast to inducer Tsl cells, Ts2 cells suppress during the effector 
phase  of the  immune  response.  The  hybridoma  Ts2  cells  described  in  this  report 
produce  a  suppressor  factor  termed  TsF2,  which  bears  I-J  determinants  and  has 
binding specificity for NP  b idiotype;  this  factor probably corresponds to the  factor 
characterized by Dietz et al. (19)  in another suppressor cell system. Monoclonal TsF2 
factor is  restricted  by both  H-2 and  Igh genes.  There are suggestions  that  the Ts2 
population might be heterogeneous (20). The presumed target of TsF2 is an antigen- 
primed, I-J  +, Lyt-2  + cell population that bears idiotypic determinants (4).2 This third 
2  Sherr, D. H., and M.  E. Dorf. Hapten-specific  T cell responses to 4-hydroxy-3-nitrophenyl  acetyl. 
XIII. Characterization of a third order T cells (Ts3) involved in suppression of in vitro PFC responses. 
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cell population is termed Tsa. NP-specific Ts3 cells are poorly characterized but have 
been identified in cell preparations from antigen-primed lymph nodes (4). Hybridoma 
Tsa lines have not yet been described. Thus, some of the properties of Ts3 cells may be 
attributable to distinct  T  cell subsets that are present  in the mixed Ts3 population. 
The  Tsa  population  or  a  factor  (TsF3)  produced  by  this  population  may  interact 
directly or indirectly  (via other cellular intermediates) with the T  cells that mediate 
CS or helper activity for Npb-specific B cells. The precise nature and mechanism of 
the final phase of immune suppression remains unresolved. Experiments are underway 
to prepare Ts3 hybridomas to help clarify some of the outstanding questions concern- 
ing the final phases of the suppressor T  cell pathway. 
Summary 
Five hybridoma T  cell lines were prepared by fusion of second order suppressor T 
cells  (Ts2)  with  the  BW5147  thymoma.  The  culture  supernates  from  these  T  cell 
hybrids  contained  a  factor,  TsF2,  which  specifically  suppressed  4-hydroxy-3-nitro- 
phenyl acetyl hapten (NP)-induced cutaneous sensitivity responses. TsF2 activity was 
observed when the factor was administered during the effector phases of the immune 
response. TsF2 bears I-J determinants  and has binding specificity for NP  b idiotypic 
determinants.  TsF2  suppressor  activity could  be absorbed  on  antigen-primed  H-2- 
incompatible T  cells but cannot suppress H-2-incompatible mice. In addition to this 
H-2 restriction,  which  maps to the I-J subregion,  monoclonal TsF2 also has an Igh 
genetic restriction. The present results are combined with previous data to describe 
the cellular interactions leading to immune suppression. 
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